PNC Financial Services Group’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7K Buy
1,386
+792
+133% +$9.13K ﹤0.01% 3921
2026
Q1
$6.05K Sell
594
-571
-49% -$6.16K ﹤0.01% 4175
2025
Q4
$12.4K Buy
1,165
+18
+2% +$215 ﹤0.01% 3864
2025
Q3
$15.7K Sell
1,147
-854
-43% -$11.9K ﹤0.01% 3744
2025
Q2
$28.1K Buy
2,001
+1,448
+262% +$19K ﹤0.01% 3410
2025
Q1
$7.46K Buy
553
+247
+81% +$3.71K ﹤0.01% 3927
2024
Q4
$5.39K Buy
306
+183
+149% +$3.4K ﹤0.01% 4018
2024
Q3
$2.35K Sell
123
-194
-61% -$3.74K ﹤0.01% 4260
2024
Q2
$6.92K Sell
317
-1,270
-80% -$33.9K ﹤0.01% 3907
2024
Q1
$60.8K Buy
1,587
+446
+39% +$21.6K ﹤0.01% 2898
2023
Q4
$76.7K Sell
1,141
-1,036
-48% -$72.2K ﹤0.01% 2753
2023
Q3
$163K Buy
2,177
+95
+5% +$8.43K ﹤0.01% 2261
2023
Q2
$192K Buy
2,082
+611
+42% +$54.4K ﹤0.01% 2223
2023
Q1
$152K Buy
1,471
+54
+4% +$5.98K ﹤0.01% 2313
2022
Q4
$163K Buy
1,417
+34
+2% +$3.96K ﹤0.01% 2258
2022
Q3
$149K Buy
1,383
+75
+6% +$10.7K ﹤0.01% 2285
2022
Q2
$236K Buy
1,308
+37
+3% +$6.62K ﹤0.01% 2035
2022
Q1
$217K Buy
1,271
+468
+58% +$88.2K ﹤0.01% 2197
2021
Q4
$168K Sell
803
-498
-38% -$103K ﹤0.01% 2361
2021
Q3
$251K Sell
1,301
-24
-2% -$5.9K ﹤0.01% 2043
2021
Q2
$375K Buy
1,325
+3
+0.2% +$813 ﹤0.01% 1800
2021
Q1
$281K Buy
1,322
+623
+89% +$149K ﹤0.01% 1965
2020
Q4
$137K Buy
699
+39
+6% +$6.89K ﹤0.01% 2305
2020
Q3
$107K Sell
660
-21
-3% -$3.46K ﹤0.01% 2288
2020
Q2
$94K Buy
681
+166
+32% +$15.2K ﹤0.01% 2370
2020
Q1
$33K Buy
515
+84
+19% +$7.65K ﹤0.01% 2860
2019
Q4
$48K Sell
431
-111
-20% -$10.7K ﹤0.01% 2911
2019
Q3
$56K Sell
542
-13
-2% -$1.4K ﹤0.01% 2838
2019
Q2
$70K Sell
555
-136
-20% -$18.9K ﹤0.01% 2749
2019
Q1
$88K Sell
691
-53
-7% -$6.72K ﹤0.01% 2633
2018
Q4
$94K Sell
744
-79
-10% -$13.5K ﹤0.01% 2494
2018
Q3
$184K Sell
823
-96
-10% -$19.5K ﹤0.01% 2242
2018
Q2
$147K Buy
919
+10
+1% +$1.28K ﹤0.01% 2382
2018
Q1
$85K Sell
909
-27
-3% -$2.02K ﹤0.01% 2665
2017
Q4
$64K Buy
936
+20
+2% +$1.33K ﹤0.01% 2806
2017
Q3
$55K Buy
916
+232
+34% +$11.5K ﹤0.01% 2873
2017
Q2
$28K Buy
684
+20
+3% +$869 ﹤0.01% 3182
2017
Q1
$30K Buy
664
+63
+10% +$2.71K ﹤0.01% 3119
2016
Q4
$25K Buy
+601
New +$24.2K ﹤0.01% 3136
2016
Q3
Sell
-91
Closed -$3K 4150
2016
Q2
$3K Sell
91
-4
-4% -$129 ﹤0.01% 4040
2016
Q1
$3K Buy
95
+3
+3% +$88 ﹤0.01% 4051
2015
Q4
$3K Sell
92
-208
-69% -$6.2K ﹤0.01% 4045
2015
Q3
$8K Buy
300
+3
+1% +$87 ﹤0.01% 3770
2015
Q2
$10K Buy
297
+66
+29% +$2.09K ﹤0.01% 3797
2015
Q1
$7K Hold
231
﹤0.01% 3916
2014
Q4
$8K Hold
231
﹤0.01% 3428
2014
Q3
$8K Buy
231
+90
+64% +$2.76K ﹤0.01% 3336
2014
Q2
$5K Buy
141
+90
+176% +$2.81K ﹤0.01% 3317
2014
Q1
$1K Buy
+51
New +$1.37K ﹤0.01% 3691

Other funds holding MED

PNC Financial Services Group's MED Position: Q2 2026 in Review

PNC Financial Services Group increased its Medifast (MED) stake by 133% in Q2 2026, buying an estimated $9.13K and bringing the position to 1,386 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3921.

PNC Financial Services Group first reported a position in MED in Q1 2014 and has held it in 49 quarters since. The position peaked at $375K in Q2 2021. 39 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • PNC Financial Services Group held 1,386 shares of Medifast worth $14.7K as of Q2 2026.
  • PNC Financial Services Group bought 792 Medifast shares in Q2 2026, an estimated $9.13K.
  • Medifast made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3921 holding.
  • PNC Financial Services Group first reported a position in Medifast in Q1 2014 and has held it in 49 quarters since.
  • PNC Financial Services Group's Medifast position peaked at $375K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.